Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Oral Semaglutide in Hyperglycaemic Patients After Renal Transplantation

NCT05702931 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT05702931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05702931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Oral Semaglutide in Hyperglycaemic Patients After Renal Transplantation
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 4
Overall status
Recruiting
Start date
September 19, 2024
Completion date
December 31, 2027
Enrollment
104 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hyperglycemia, renal transplant complication primary non-function